Investors Hangout Stock Message Boards Logo
  • Mailbox
  • Favorites
  • Boards
    • The Hangout
    • NASDAQ
    • NYSE
    • OTC Markets
    • All Boards
  • Whats Hot!
    • Recent Activity
    • Most Viewed Boards
    • Most Viewed Posts
    • Most Posted
    • Most Followed
    • Top Boards
    • Newest Boards
    • Newest Members
  • Blog
    • Recent Blog Posts
    • Recently Updated
    • News
    • Stocks
    • Crypto
    • Investing
    • Business
    • Markets
    • Economy
    • Real Estate
    • Personal Finance
  • Market Movers
  • Interactive Charts
  • Login - Join Now FREE!
  1. Home ›
  2. Stock Message Boards ›
  3. Stock Boards ›
  4. DarioHealth Corp. (DRIO) Message Board

Latest news. 1/22/15 http://finance.yahoo.com/

Message Board Public Reply | Private Reply | Keep | Replies (0)                   Post New Msg
Edit Msg () | Previous | Next


Post# of 188
Posted On: 01/22/2015 10:01:16 AM
Posted By: Boris Badenoff
Latest news. 1/22/15

http://finance.yahoo.com/news/labstyle-innova...00634.html


LabStyle Innovations Announces HMO Tele-Care Partnership Agreement
Agreement signed with Israel's leading healthcare provider; Maccabi Healthcare for remote support platform for diabetes
PR Newswire
LabStyle Innovations Corp. 56 minutes ago

CAESAREA, Israel, Jan. 22, 2015 /PRNewswire/ -- LabStyle Innovations Corp. (DRIO), developer of the Dario™ Diabetes Management Solution, today reported that it has signed a partnership agreement with Israel's leading healthcare HMO; Maccabi Healthcare to implement its comprehensive Dario™ digital suite for patients and professionals remote proactive care.

The agreement with MOMA (Maccabi TeleCare unit) represents an additional channel of revenue stream for Dario™. This channel for revenues indicates the huge potential available in the Dario digital health solution which is based on software licensing and added value services with HMOs and other strategic partners worldwide. The Dario™ application for MOMA is a proprietary customized diabetes management solution that enables remote treatment for diabetes aiming to improve the overall outcomes for patients leveraging mHealth technology for effective engagement of health care professionals.

Through the agreement Maccabi Healthcare will be subscribing to Dario™; a cutting edge diabetes management solution that includes an online diabetes solution together with the Dario™ personalized smart meters for an advanced service they call MOMA. Through MOMA, Maccabi will provide chronic patients a service of advanced multi-disciplinary support and care through a national call center in coordination with the client's primary physician and other community-based resources. Each MOMA member with diabetes will receive their own Dario™ smart meter for managing and monitoring their diabetes in order to enable the caretakers at the call centers a direct online view and proactive communication over the Dario™ mobile platform.

"We have witnessed in our markets overseas how the Dario™ diabetes solution has successfully increased the compliance and improved the Diabetes patient's outcomes. We are very pleased to have this superb vehicle to finally allow us to bring the Dario™ diabetes management solution to patients and care givers under the Dario™ software suite. With one of the longest life expectancy and lowest infant mortality rates, Israel's health system has been ranked one of the highest in the world, and MOMA at Maccabi represents the most advanced and innovative form of medical healthcare available in Israel. We are very proud that they have chosen Dario™ to serve their valued patients with diabetes. We believe that the MOMA agreement illustrates the tremendous potential for LabStyle in the digital health area where the company can generate and sustain revenue not only from the consumables but also from software licensing and added value services. The data monetization revenue channel will be a significant contribution to the gross margins of LabStyle," said Erez Raphael, president and chief executive officer of LabStyle.

"By providing our physicians and patients with access to the data the Dario™ management solution provides, MOMA has enhanced its capabilities for true patient online analysis and real time care and differentiated its offerings in the market for quality treatment and support. We believe that together with Dario™ we can enhance our clients' physical and mental quality of life, performance scores, compliance rates, and overall satisfaction with their health providers," said Ms. Angela Eroni, Maccabi director of medical tele-centers.


http://finance.yahoo.com/news/labstyle-innova...00634.html
.


(0)
(0)




DarioHealth Corp. (DRIO) Stock Research Links


  1.  
  2.  


  3.  
  4.  
  5.  






Investors Hangout

Home

Mailbox

Message Boards

Favorites

Whats Hot

Blog

Settings

Privacy Policy

Terms and Conditions

Disclaimer

Contact Us

Whats Hot

Recent Activity

Most Viewed Boards

Most Viewed Posts

Most Posted Boards

Most Followed

Top Boards

Newest Boards

Newest Members

Investors Hangout Message Boards

Welcome To Investors Hangout

Stock Message Boards

American Stock Exchange (AMEX)

NASDAQ Stock Exchange (NASDAQ)

New York Stock Exchange (NYSE)

Penny Stocks - (OTC)

User Boards

The Hangout

Private

Global Markets

Australian Securities Exchange (ASX)

Euronext Amsterdam (AMS)

Euronext Brussels (BRU)

Euronext Lisbon (LIS)

Euronext Paris (PAR)

Foreign Exchange (FOREX)

Hong Kong Stock Exchange (HKEX)

London Stock Exchange (LSE)

Milan Stock Exchange (MLSE)

New Zealand Exchange (NZX)

Singapore Stock Exchange (SGX)

Toronto Stock Exchange (TSX)

Contact Investors Hangout

Email Us

Follow Investors Hangout

Twitter

YouTube

Facebook

Market Data powered by QuoteMedia. Copyright © 2025. Data delayed 15 minutes unless otherwise indicated (view delay times for all exchanges).
Analyst Ratings & Earnings by Zacks. RT=Real-Time, EOD=End of Day, PD=Previous Day. Terms of Use.

© 2025 Copyright Investors Hangout, LLC All Rights Reserved.

Privacy Policy |Do Not Sell My Information | Terms & Conditions | Disclaimer | Help | Contact Us